MX2010001825A - Sulfonil azabiciclo[3.2.1]octanos 6-sustituidos utiles para inhibir 11beta-hidroxiesteroide deshidrogenasa tipo-1. - Google Patents
Sulfonil azabiciclo[3.2.1]octanos 6-sustituidos utiles para inhibir 11beta-hidroxiesteroide deshidrogenasa tipo-1.Info
- Publication number
- MX2010001825A MX2010001825A MX2010001825A MX2010001825A MX2010001825A MX 2010001825 A MX2010001825 A MX 2010001825A MX 2010001825 A MX2010001825 A MX 2010001825A MX 2010001825 A MX2010001825 A MX 2010001825A MX 2010001825 A MX2010001825 A MX 2010001825A
- Authority
- MX
- Mexico
- Prior art keywords
- hydroxysteroid dehydrogenase
- azabicyclo
- inhibit
- dehydrogenase type
- useful
- Prior art date
Links
- 101710088194 Dehydrogenase Proteins 0.000 title abstract 3
- 125000000472 sulfonyl group Chemical class *S(*)(=O)=O 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95598507P | 2007-08-15 | 2007-08-15 | |
| PCT/US2008/009609 WO2009023181A1 (en) | 2007-08-15 | 2008-08-12 | 6-SUBSTITUTED SULFONYL AZABICYCLO[3.2.1]OCTANES USEFUL TO INHIBIT 11β-HYDROXYSTEROID DEHYDROGENASE TYPE-1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010001825A true MX2010001825A (es) | 2010-03-10 |
Family
ID=39944385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010001825A MX2010001825A (es) | 2007-08-15 | 2008-08-12 | Sulfonil azabiciclo[3.2.1]octanos 6-sustituidos utiles para inhibir 11beta-hidroxiesteroide deshidrogenasa tipo-1. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8466149B2 (enExample) |
| EP (1) | EP2188293B1 (enExample) |
| JP (1) | JP2010536750A (enExample) |
| CN (1) | CN101821271A (enExample) |
| CA (1) | CA2696288A1 (enExample) |
| MX (1) | MX2010001825A (enExample) |
| WO (1) | WO2009023181A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| JPWO2019026575A1 (ja) * | 2017-08-04 | 2020-06-18 | 国立大学法人東海国立大学機構 | 花成時期調節剤、農薬組成物及び植物の花成時期の調節方法 |
| EP4157263A4 (en) * | 2020-05-26 | 2024-09-11 | The Regents Of The University Of Michigan | Mitochondrial targeting compounds for the treatment of associated diseases |
| CN111743898A (zh) * | 2020-06-11 | 2020-10-09 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | 11β-HSD1抑制剂在应激环境下保护神经干细胞的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL154306A0 (en) * | 2003-02-05 | 2003-09-17 | Rimonyx Pharmaceuticals Ltd | Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof |
| AU2006315436A1 (en) | 2005-11-15 | 2007-05-24 | Vertex Pharmaceuticals Incorporated | Azaindazoles useful as inhibitors of kinases |
| KR101486026B1 (ko) * | 2007-05-10 | 2015-01-22 | 도그우드 파마슈티컬스, 아이엔씨. | 플루오렌, 안트라센, 잔텐, 디벤조수베론 및 아크리딘의 유도체 및 이의 용도 |
-
2008
- 2008-08-12 US US12/672,817 patent/US8466149B2/en active Active
- 2008-08-12 EP EP08795217.2A patent/EP2188293B1/en active Active
- 2008-08-12 WO PCT/US2008/009609 patent/WO2009023181A1/en not_active Ceased
- 2008-08-12 MX MX2010001825A patent/MX2010001825A/es not_active Application Discontinuation
- 2008-08-12 CN CN200880112336A patent/CN101821271A/zh active Pending
- 2008-08-12 CA CA2696288A patent/CA2696288A1/en not_active Abandoned
- 2008-08-12 JP JP2010521002A patent/JP2010536750A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009023181A1 (en) | 2009-02-19 |
| EP2188293A1 (en) | 2010-05-26 |
| JP2010536750A (ja) | 2010-12-02 |
| EP2188293B1 (en) | 2019-05-01 |
| US8466149B2 (en) | 2013-06-18 |
| US20110237559A1 (en) | 2011-09-29 |
| CN101821271A (zh) | 2010-09-01 |
| CA2696288A1 (en) | 2009-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010001823A (es) | Piperidinil- y piperazinil-sulfonamidas biciclicas sustituidas utiles para inhibir 11beta-hidroxiesteroide deshidrogenasa tipo-1. | |
| TW200608979A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
| MX2009005455A (es) | (r)-n-estereoisomeros de analogos de 7,8-saturados-4,5 epoxi-morfinano. | |
| TW200740799A (en) | Alpha2C adrenoreceptor agonists | |
| GB0625648D0 (en) | Compounds | |
| WO2007097931A3 (en) | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
| WO2007136603A3 (en) | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
| MX2008012490A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes. | |
| JO2870B1 (en) | Amino Tetra Hydro Pirans as Inhibitors of Peptide Dipeptide IV for the Treatment or Prevention of Diabetes | |
| TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
| PL2134704T3 (pl) | Związki i kompozycje pełniące rolę modulatorów aktywności GPR119 | |
| WO2007087231A3 (en) | Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
| MX2009005461A (es) | N-oxidos de analogos de 4,5-epoxi-morfinano. | |
| WO2008013840A3 (en) | Erastin analogs and uses thereof | |
| WO2007111948A3 (en) | Inhibitors of protein prenyltransferases | |
| IN2012DN00721A (enExample) | ||
| TW200806300A (en) | New therapeutic combinations for the treatment of depression | |
| WO2007103719A3 (en) | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | |
| UA94417C2 (ru) | Замещенные 7-азаиндазолы, композиция, которая их содержит, и применение | |
| WO2007109230A3 (en) | Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith | |
| MX2009010960A (es) | Compuestos heterociclicos y sus metodos de uso. | |
| WO2008073332A3 (en) | Creatine compositions for skin treatment | |
| MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
| TW200722081A (en) | New therapeutic combinations for the treatment or prevention of depression | |
| NZ594019A (en) | Novel antibacterial agents for the treatment of gram positive infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |